Center for Soft and Living Matter would like to share our recent study on COVID-19 to help those who are fighting back with the coronavirus pandemic.
"Suggestions for second-pass anti-COVID-19 drugs based on the Artificial Intelligence measures of molecular similarity, shape and pharmacophore distribution."
